[1] Cidon EU, Centeno RG, Lagarto EG, et al.HER-2 evaluation in a specific gastric cancer population with the highest rate of mortality in Spain[J]. J Oncol, 2011:391564 [Epub2011 Oct 27]. [2] Ye H, Jing YF, Shu DX.Can the incidence of gastric cancer be reduced in the new century[J]. J Digest Dis, 2013, 14(1):11-15. [3] Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90. [4] He YT, Hou J, Chen ZF, et al.Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China[J]. Eur J Cancer Prev, 2008, 17(2):71-76. [5] Jin H, Pinheiro PS, Callahan KE, et al.Examining the gastric cancer survival gap between Asians and whites in the United States[J]. Gastric Cancer, 2016 [Epub ahead of print]. [6] 刘天艺, 焦宇飞. 胃黏膜活检标本中上皮内瘤变及早期癌的病理诊断[J]. 中华病理学杂志, 2014, 43(9):644-646. [7] 王江红, 项颖. 早期胃癌的筛查现状及诊断进展[J]. 重庆医学, 2009, 38(20):2634-2636. [8] Dan Liu, Ming Lu, Jian Li, et al.The patterns and timing of recurrence after curative resection for gastric cancer in China[J]. World J Surg Oncol, 2016, 14(1), 305. [9] Binn M, Ruskonéfourmestraux A, Lepage E, et al.Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma[J]. Ann Oncol, 2003, 14(12):1751-1757. [10] Moelans CB, Milne AN, Morsink FH, et al.Low frequency of HER2 amplification and overexpression in early onset gastric cancer[J]. Cell Oncol (Dordr), 2011, 34(2):89-95. [11] Liu KH, Hung CY, Lu CH, et al.Survival outcomes of geriatric patients with clinically resectable gastric cancer: to operate or not[J]. J Surg Res, 2016, 206(2):481-489. [12] Thiel A.Targeted therapy in gastric cancer[J]. APMIS, 2015, 123(5):365-372. [13] Li C, Zou J, Zheng G, et al.MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells[J]. Med Sci Monit, 2016, 22:4509-4515. [14] Tang QF, Sun J, Yu H, et al.The Zuo Jin Wan formula induces mitochondrial apoptosis of cisplatin-resistant gastric cancer cells via Cofilin-1[J]. Evid Based Complement Alternat Med, 2017, 2017(1):8203189. [15] 许春花, 杨磊, 汤旭蓁,等. 人源性胃癌移植瘤模型的初步建立及其评价[J]. 实验动物与比较医学, 2014, 34(4): 259-265. [16] 崔晋峰, 赵晨燕, 曹立勇,等. 食管胃交界腺癌和远端胃癌KLF4SP1及CyclinD1表达的对比研究[J]. 中国肿瘤临床, 2014, 41(2):108-112. [17] 李平. 浅谈胃癌的中医药治疗[J]. 中医药临床杂志, 2011, 23(3):207-208. [18] Terashima M, Irinoda T, Fujiwara H, et al.Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer[J]. Anticancer Res, 2002, 22(2A):761-768. [19] Qin B, Tanaka R, Shibata Y, et al.In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines[J]. Anticancer Drugs, 2006, 17(4):445-453. [20] Zhang X Q, Zhang H M, Sun X E, et al.Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice[J]. Exp Ther Med, 2015, 9(1):105-111. [21] Chabner BA.NCI-60 Cell Line Screening: A Radical Departure in its Time[J]. J Natl Cancer Inst, 2016, 108(5). |